DSIP and the sleep problem: how would you even test this?

DSIP was discovered in 1977, named for the sleep state it was isolated from, and has been studied on and off ever since without resolving into anything. evidence: early.

What interests me is the methodological problem, because it recurs across half this site. Better sleep is the single most commonly reported effect of almost every compound discussed here — epitalon, ipamorelin, DSIP, others. That cannot all be real.

How would you actually test a sleep claim properly?

Badly, is the short answer, which is why fifty years has not settled it.

The problems, roughly in order of how much damage they do:

Self-report is nearly worthless here. Perceived sleep quality correlates poorly with measured sleep. People routinely report sleeping well on nights that polysomnography says were fragmented, and badly on nights that were fine.

The act of measuring changes it. Sleeping in a lab with electrodes is not sleeping.

Enormous night-to-night variance. Which means a small effect needs a lot of nights or a lot of people, and almost no study of this kind has either.

Expectation is unusually powerful. Sleep is close to the maximally suggestible endpoint. You take something at bedtime believing it will help you sleep. Also: you have now established a bedtime routine and are thinking about sleep on purpose, both of which are actual sleep hygiene interventions.

So a compound taken before bed has to beat placebo and beat the behavioural intervention of taking a compound before bed.

Which is why "users consistently report better sleep" should reduce your confidence rather than increase it. It is exactly what you would observe if nothing were happening.

If the same reported effect appears across compounds with entirely unrelated mechanisms — a pineal tetrapeptide, a ghrelin receptor agonist, and a 1977 sleep fragment — the parsimonious explanation is not that all three work.

That is the inference I was fishing for. A finding that shows up regardless of mechanism is a finding about the measurement, not the mechanism.

In fairness to DSIP: the reason it has been studied on and off for fifty years without dying is that there is something there in the original isolation work. It is not a marketing invention. It is a real endogenous peptide with a real history.

It just has not converted into a demonstrated effect in humans, and early is the right label for that — better than none, nowhere near mixed.

Fifty years of on-and-off study without resolution is itself informative. Compounds with large effects do not stay ambiguous that long.